Zhirong Shen joined BeiGene in August 2015 and is Vice President, Global Head of Translational Discovery, Research and Medicine. He is an experienced leader in drug discovery, translational research, and development. Prior to joining BeiGene, he was Director of Metabolomics Center at National Institute of Biological Sciences, Beijing (NIBS).

Dr. Shen received his B.S. in 2003 from Nanjing University and obtained his Ph.D. in Basic Biomedical Science in 2010 from the University of Texas Southwestern Medical Center at Dallas (UTSW). He completed his post-doctoral training at UTSW and NIBS with Dr. Xiaodong Wang. Dr. Shen’s research interests span broad areas, including cancer biology, cancer immunology, and drug resistance mechanisms of anti-cancer targeted therapy and immunotherapy.